ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,040,205 | -86.1% | 29,178 | -82.0% | 0.01% | -84.0% |
| Q2 2023 | $7,488,461 | -19.8% | 162,334 | -30.3% | 0.05% | -12.3% |
| Q1 2023 | $9,342,017 | -10.5% | 232,968 | +3.4% | 0.06% | -6.6% |
| Q4 2022 | $10,433,470 | +3.0% | 225,199 | -7.9% | 0.06% | +7.0% |
| Q3 2022 | $10,128,000 | +1172.4% | 244,579 | +1734.3% | 0.06% | +1040.0% |
| Q2 2022 | $796,000 | -72.7% | 13,334 | -66.8% | 0.01% | -80.0% |
| Q1 2022 | $2,916,000 | +378.8% | 40,153 | +454.6% | 0.02% | +316.7% |
| Q4 2021 | $609,000 | -82.9% | 7,240 | -81.6% | 0.01% | -86.7% |
| Q3 2021 | $3,558,000 | -79.6% | 39,448 | -78.4% | 0.04% | -77.0% |
| Q2 2021 | $17,431,000 | +343.3% | 182,808 | +429.4% | 0.20% | +292.0% |
| Q1 2021 | $3,932,000 | -61.2% | 34,534 | -52.9% | 0.05% | -64.0% |
| Q4 2020 | $10,140,000 | +263.6% | 73,249 | +115.9% | 0.14% | +239.0% |
| Q3 2020 | $2,789,000 | +477.4% | 33,932 | +212.4% | 0.04% | +215.4% |
| Q1 2020 | $483,000 | -43.3% | 10,863 | -45.6% | 0.01% | -18.8% |
| Q4 2019 | $852,000 | -46.6% | 19,956 | -46.5% | 0.02% | -50.0% |
| Q3 2019 | $1,596,000 | +762.7% | 37,302 | +1183.6% | 0.03% | +966.7% |
| Q2 2019 | $185,000 | -78.7% | 2,906 | -85.4% | 0.00% | -92.7% |
| Q4 2018 | $867,000 | +38.1% | 19,929 | +142.4% | 0.04% | +20.6% |
| Q3 2018 | $628,000 | +375.8% | 8,220 | +217.1% | 0.03% | +325.0% |
| Q1 2018 | $132,000 | -50.7% | 2,592 | -55.1% | 0.01% | -42.9% |
| Q4 2017 | $268,000 | -45.9% | 5,777 | -37.8% | 0.01% | -50.0% |
| Q3 2017 | $495,000 | +43.1% | 9,287 | +66.7% | 0.03% | +27.3% |
| Q2 2017 | $346,000 | +68.0% | 5,570 | +83.7% | 0.02% | +46.7% |
| Q1 2017 | $206,000 | -53.0% | 3,032 | -56.2% | 0.02% | -40.0% |
| Q1 2016 | $438,000 | +13.2% | 6,921 | +100.7% | 0.02% | +8.7% |
| Q4 2015 | $387,000 | -67.3% | 3,449 | -72.0% | 0.02% | -61.7% |
| Q3 2015 | $1,185,000 | +28.9% | 12,300 | -16.9% | 0.06% | +33.3% |
| Q1 2015 | $919,000 | +100.2% | 14,808 | +41.7% | 0.04% | +80.0% |
| Q4 2014 | $459,000 | – | 10,452 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |